Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in Massachusetts, automatically classified by Maddy, our AI policy reader.

Total bills
1,124
194th Legislature (2025-2026)
Top supporter
Dave Muradian
100% support rate
Top opponent
Aaron Saunders
11% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in Massachusetts

Legislators moving healthcare in Massachusetts
Legislator Party Stance Support rate Decisive votes
Dave Muradian
Dave Muradian House · District 9th Worcester
R
Strong +
100% 9
Donald Wong
Donald Wong House · District 9th Essex
R
Strong +
100% 9
Dave Vieira
Dave Vieira House · District 3rd Barnstable
R
Strong +
89% 9
David DeCoste
David DeCoste House · District 5th Plymouth
R
Strong +
89% 9
John Gaskey
John Gaskey House · District 2nd Plymouth
R
Strong +
89% 9
Aaron Saunders
Aaron Saunders House · District 7th Hampden
D
Strong −
11% 9
Amy Sangiolo
Amy Sangiolo House · District 11th Middlesex
D
Strong −
11% 9
Priscila Sousa
Priscila Sousa House · District 6th Middlesex
D
Strong −
14% 7
Alan Silvia
Alan Silvia House · District 7th Bristol
D
Oppose
22% 9
Dan Sena
Dan Sena House · District 37th Middlesex
D
Oppose
22% 9
Showing 51–60 of 1,124 bills

All healthcare bills

passed · Massachusetts · House May 21, 2026

H 5443: An Act relative to increasing access to epinephrine

This bill allows restaurants, schools, sports leagues, and other public venues to purchase and keep epinephrine autoinjectors on-site to treat severe allergic reactions. To do so, these locations must get approval from the state department, ensure their staff completes specific emergency training, and store the devices in easily accessible places. Trained employees are authorized to use these injectors on anyone showing signs of anaphylaxis, even if the person does not have a personal prescription for the medication. The law also provides legal protection from lawsuits for these venues and their staff when administering the drug in good faith, while requiring them to report each use to the state for public analysis.
in committee · Massachusetts · Senate May 26, 2026

S 3068: An Act protecting patient safety regarding non-FDA approved drugs

The committee on Health Care Financing to whom was referred the Senate Bill protecting patient safety regarding non-FDA approved drugs (Senate, No. 1497), - reports, recommending that the same ought to pass with an amendment substituting a new draft with the same title (Senate, No. 3068).
introduced · Massachusetts · House May 28, 2026

HD 6096: A communication from the Executive Office of Health and Human Services (see Section 219 of Chapter 6 of the General Laws) submitting the Community Behavioral Health Promotion and Prevention Commission annual report for fiscal year 2026

This bill serves as a formal communication submitting the annual report for the Community Behavioral Health Promotion and Prevention Commission for fiscal year 2026. The document outlines the commission's role in promoting mental health, preventing substance use disorders, and advising the state legislature on evidence-based policies. It details the commission's 23-member structure, which includes government officials, legislative leaders, and representatives from various health and social service organizations. The text also specifies the commission's duties, such as analyzing data, coordinating wellness programs, and making recommendations to reduce public health costs.
in committee · Massachusetts · House Apr 23, 2026

H 5385: An Act to provide rapid whole genome sequencing

This bill directs Massachusetts health officials to cover rapid whole genome sequencing for Medicaid patients under 21 who have complex or acute illnesses of unknown cause while in intensive care. The test, which analyzes a patient's entire genetic code to find disease-causing changes, must return preliminary results within five days and final results within two weeks. Coverage is limited to cases where the patient exhibits specific severe symptoms, such as multiple congenital anomalies, refractory seizures, or abnormal heart function, and where timely genetic diagnosis is necessary to guide treatment. To support this new service, the bill requires the state to set a separate reimbursement rate for hospitals that performs the testing outside of standard bundled payments.
Sub-Topics Medicaid
introduced · Massachusetts · House May 18, 2026

HD 6053: A communication from the Massachusetts Health Policy Commission (see Section 145 of Chapter 126 of the Acts of 2022) submitting a report entitled: “Emergency Boarding in the Commonwealth of Massachusetts”

This bill serves as a formal communication from the Massachusetts Health Policy Commission to the General Court, submitting a report on emergency department boarding in the state. The document analyzes data on patient wait times and outlines existing strategies, such as the Expedited Admissions Task Force and community behavioral health centers, designed to divert patients from overcrowded emergency rooms. It details specific findings regarding how long different age groups wait for care and reviews the effectiveness of current policies aimed at reducing these delays. Ultimately, the bill provides a factual record of the state's efforts to manage emergency boarding without proposing new legislative changes.
introduced · Massachusetts · House Apr 8, 2026

HD 6001: The final report of the Special Commission on the Public Health and Safety Concerns Posed by the Proliferation of Xylazine as an Additive to Illicit Drugs, Including, but not limited to, Fentanyl (under Chapter 285 of the Acts of 2024, as amended by Section 95 of Chapter 14 of the Acts of 2025) on recommendations on ways to address the matter

This bill establishes a special commission to investigate the public health and safety risks associated with xylazine being mixed with illicit drugs like fentanyl. The commission will review current data and propose specific strategies to address the growing problem of xylazine use in Massachusetts. The findings and recommendations from this study will be compiled into a final report for legislative consideration. The primary focus is on creating actionable solutions to mitigate the dangers posed by this drug additive.
Sub-Topics Public Health
introduced · Massachusetts · House Apr 8, 2026

H 5349: Amendment H.5349

Text of amendments, recommended by the committee on Ways and Means, to the Senate Bill to promote student learning and mental health (Senate, No. 2581, amended). April 7, 2026.
introduced · Massachusetts · House Apr 8, 2026

H 5366: Amendment H.5366

Text of the House amendments to the Senate Bill to promote student learning and mental health (Senate, No. 2581) (being the text of House document numbered 5349, published as amended). April 8, 2026.
passed · Massachusetts · Senate Jun 15, 2026

S 3056: An Act relative to medication administration in rest homes

By Mr. Moore, a petition (accompanied by bill, Senate, No. 3056) (subject to Joint Rule 12) of Michael O. Moore, Patricia D. Jehlen, Robyn K. Kennedy, John J. Marsi and others for legislation relative to medication administration in rest homes. Aging and Independence.
in committee · Massachusetts · House Mar 23, 2026

H 5283: An Act relative to providing health education in schools

This bill amends Massachusetts education laws to formally include health education as part of the required curriculum in public schools. It mandates that health education standards be age-appropriate and medically accurate, covering topics such as physical development, nutrition, mental health, substance use prevention, and community health. The legislation also requires school districts to notify parents when implementing sexual education curricula and allows parents to request exemptions for their children without penalty. Additionally, the bill clarifies that the state's health curriculum framework serves as a guide for local districts and explicitly states that health education will not be tested on the MCAS exam.
Showing 51 to 60 of 1,124 bills
Previous 1 … 5 6 7 … 113 Next